<?xml version="1.0" encoding="UTF-8"?>
<p id="Par42">The inclusion of high-risk groups (such as elderly individuals, pregnant women and children) is also important to ensure generalisability of outbreak research. During the influenza A(H1N1)pdm09 pandemic, elderly and paediatric individuals were included in 88 and 93% of publications, respectively, noting again that the vast majority of these studies were observational only. At the onset of the pandemic, however, trials for approved neuraminidase inhibitors had only been conducted for mild seasonal influenza in healthy adults [
 <xref ref-type="bibr" rid="CR28">28</xref>], without the inclusion of those highest at risk. A failure to include high-risk groups in initial prospective trials for novel medications may further delay the evidence base for these individuals when drugs are employed under outbreak circumstances.
</p>
